These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1296829)

  • 1. Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.
    Occas Pap R Coll Gen Pract; 1992 Mar; (55):1-15. PubMed ID: 1296829
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hyperlipidaemia.
    Stocks N; Allan J; Mansfield PR
    Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia.
    Bradley A; Elliott J; White H
    N Z Med J; 1993 Jun; 106(958):243-7. PubMed ID: 8332291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia.
    Hobbs FD; Holmes J; Pugner K
    Br J Gen Pract; 1998 Feb; 48(427):983-4. PubMed ID: 9624770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the primary health care team in coronary heart disease prevention.
    Calnan M; Cant S; Williams S; Killoran A
    Br J Gen Pract; 1994 May; 44(382):224-8. PubMed ID: 8204337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can audit of a local protocol for the management of lipid disorders effect and detect a change in clinical practice?
    Bain NS; Foster K; Grimshaw J; MacLeod TN; Broom J; Reid J; Ritchie LD
    Health Bull (Edinb); 1997 Mar; 55(2):94-102. PubMed ID: 9330497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 10. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary coronary heart disease prevention in general practice. How does one recognize and define a risk patient?].
    Schwandt P
    MMW Fortschr Med; 1999 Oct; 141(43):26-8. PubMed ID: 10912117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low adherence of General Practitioners to National Cholesterol Education Program guidelines for the management of hyperlipidaemia.
    Fornengo P; Bruno G; De Salvia A; Arcari R; Pisu E; Pagano G
    Diabetes Nutr Metab; 2000 Oct; 13(5):263-8. PubMed ID: 11105968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The general practitioner's role in the prevention of coronary heart disease.
    Fowler G
    Practitioner; 1986 Oct; 230(1420):859-62, 864. PubMed ID: 3658893
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of elevated cholesterol levels by New Hampshire primary care physicians.
    Vivier PM; Dietrich AJ; Witters LA
    J Fam Pract; 1988 Aug; 27(2):167-72. PubMed ID: 3404101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How can primary prevention of coronary heart disease be improved in general practice?].
    Wicklmayr M; Rett K; Standl E
    Med Klin (Munich); 1994 Apr; 89(4):184-6, 229. PubMed ID: 8015531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues in the treatment of hyperlipidaemias.
    Janus ED
    Aust Fam Physician; 1993 Feb; 22(2):212-4, 217, 220-1. PubMed ID: 8447792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease prevention: better management of dyslipidemias required.
    Teo KK
    Can J Cardiol; 1997 Feb; 13(2):127-8. PubMed ID: 9070163
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study].
    Amouyel P; Farnier M; Lyon G; Siest G; Mortier N; Amiot N; Duprat-Lomon I
    Arch Mal Coeur Vaiss; 2001 Oct; 94(10):1045-53. PubMed ID: 11725709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for cholesterol management: recommendations of the National Cholesterol Education Program's Adult Treatment Panel II.
    Grundy SM
    Heart Dis Stroke; 1994; 3(3):123-7. PubMed ID: 8044423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.